Correlation Between AnaptysBio and Lyell Immunopharma
Can any of the company-specific risk be diversified away by investing in both AnaptysBio and Lyell Immunopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AnaptysBio and Lyell Immunopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AnaptysBio and Lyell Immunopharma, you can compare the effects of market volatilities on AnaptysBio and Lyell Immunopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AnaptysBio with a short position of Lyell Immunopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of AnaptysBio and Lyell Immunopharma.
Diversification Opportunities for AnaptysBio and Lyell Immunopharma
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between AnaptysBio and Lyell is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding AnaptysBio and Lyell Immunopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyell Immunopharma and AnaptysBio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AnaptysBio are associated (or correlated) with Lyell Immunopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyell Immunopharma has no effect on the direction of AnaptysBio i.e., AnaptysBio and Lyell Immunopharma go up and down completely randomly.
Pair Corralation between AnaptysBio and Lyell Immunopharma
Given the investment horizon of 90 days AnaptysBio is expected to under-perform the Lyell Immunopharma. But the stock apears to be less risky and, when comparing its historical volatility, AnaptysBio is 1.13 times less risky than Lyell Immunopharma. The stock trades about -0.08 of its potential returns per unit of risk. The Lyell Immunopharma is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 95.00 in Lyell Immunopharma on August 30, 2024 and sell it today you would lose (3.00) from holding Lyell Immunopharma or give up 3.16% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
AnaptysBio vs. Lyell Immunopharma
Performance |
| Timeline |
| AnaptysBio |
| Lyell Immunopharma |
AnaptysBio and Lyell Immunopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AnaptysBio and Lyell Immunopharma
The main advantage of trading using opposite AnaptysBio and Lyell Immunopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AnaptysBio position performs unexpectedly, Lyell Immunopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyell Immunopharma will offset losses from the drop in Lyell Immunopharma's long position.| AnaptysBio vs. Crinetics Pharmaceuticals | AnaptysBio vs. Rhythm Pharmaceuticals | AnaptysBio vs. Kura Oncology | AnaptysBio vs. CytomX Therapeutics |
| Lyell Immunopharma vs. Cullinan Oncology LLC | Lyell Immunopharma vs. Monte Rosa Therapeutics | Lyell Immunopharma vs. Revolution Medicines | Lyell Immunopharma vs. Nkarta Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |